Astrid Beyerle
Mayo Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Astrid Beyerle.
Free Radical Biology and Medicine | 1999
Dominik Peus; Alexander Meves; R Vasa; Astrid Beyerle; Timothy O’Brien; Mark R. Pittelkow
Ultraviolet radiation (UVR)-induced receptor phosphorylation is increasingly recognized as a widely occurring phenomenon. However, the mechanisms, mediators, and sequence of events involved in this process remain ill-defined. We have recently shown that exposure of human keratinocytes to physiologic doses of ultraviolet B radiation (UVB) activates epidermal growth factor receptor (EGFR)/extracellular-regulated kinase 1 and 2 (ERK1/2), and p38 signaling pathways via reactive oxygen species. Here we demonstrate that UVB exposure increased intra- and extracellular H2O2 production rapidly in a time-dependent manner. An EGFR-specific monoclonal antibody abrogated EGFR autophosphorylation and markedly decreased the phosphorylation of ERK1/2 whereas p38 activation was unaffected. Overexpression of catalase strongly inhibited UVB-induced EGFR/ERK1/2 pathway activation. These findings establish the sequence of events after UVB irradiation: (i) H2O2 generation, (ii) EGFR phosphorylation, and (iii) ERK activation. Our results identify UVB-induced H2O2 as a second messenger that is required for EGFR and dependent downstream signaling pathways activation.
Photochemistry and Photobiology | 2000
Dominik Peus; R Vasa; Alexander Meves; Astrid Beyerle; Mark R. Pittelkow
Abstract We have recently shown that UVB radiation activates epidermal growth factor receptor (EGFR)/extracellular regulated kinase 1 and 2 (ERK1/2) and p38 signaling pathways in keratinocytes. However, the functional relevance of these processes for downstream signaling and cell survival remains to be determined. The specific EGFR inhibitor PD153035 markedly decreased UVB-induced phosphorylation of EGFR, ERK1/2 and shc, whereas p38 activation was unaffected. PD153035 pretreatment followed by UVB reduced clonogenic potential and enhanced peroxide production, apoptosis and cell death. Our data suggest that ligand-independent phosphorylation of EGFR and likely dependent downstream signaling pathways regulate cellular defense mechanisms important for cell survival following oxidative stress.
Toxicology Letters | 2001
Alexander Meves; Sibylle N. Stock; Astrid Beyerle; Mark R. Pittelkow; Dominik Peus
We used a well-established thiol-alkylating agent, N-ethylmaleimide (NEM), to oxidatively stress human keratinocytes. Time course studies revealed that NEM rapidly depleted keratinocytes of reduced glutathione (GSH), which was followed by rapidly increasing levels of intracellular reactive oxygen species (ROS) and subsequently by phosphorylation of epidermal growth factor receptor (EGFR). Pretreatment with antioxidants or enhanced catalase activity in keratinocytes inhibited ROS/H(2)O(2) accumulation and EGFR phosphorylation, demonstrating that H(2)O(2) production is a mediator required for EGFR phosphorylation. Collectively, these results suggest a sequence of events leading to EGFR phosphorylation which is likely shared by oxidative stress-inducing agents, namely: (1) GSH depletion; (2) H(2)O(2) accumulation; and (3) EGFR phosphorylation. We propose that depletion of GSH and accumulation of H(2)O(2) are upstream events and critical mediators required for ligand-independent phosphorylation of growth factor receptors in response to oxidative stress.
Free Radical Biology and Medicine | 2001
Dominik Peus; Alexander Meves; Markus Pott; Astrid Beyerle; Mark R. Pittelkow
We have recently shown that exposure of human keratinocytes to physiologic doses of ultraviolet B (UVB) activates epidermal growth factor receptor (EGFR)/extracellular-regulated kinases 1 and 2 (ERK1/2) and p38 signaling pathways via reactive oxygen species, an effect that can be modulated by antioxidants. Trolox, a water-soluble vitamin E analog, is among the antioxidants that are currently being investigated for their preventive and protective potential against harmful effects of UV radiation to the skin. We found that Trolox inhibits both basal and UVB-induced intracellular H(2)O(2) generation in primary keratinocytes in a concentration-dependent manner. Trolox did not significantly affect UVB-induced phosphorylation of EGFR. Stronger inhibition was observed for ERK1/2 activation at lower, and for p38 activation at higher, concentrations of Trolox added to cells before exposure to UVB. Similarly different effects were found with regard to length of pretreatment with Trolox before UVB exposure-increasing inhibition for ERK1/2 activation at shorter, and for p38 activation at longer, pretreatment intervals. UVB-induced c-jun-N-terminal kinase activation was potently suppressed by Trolox. Also, increasing the pretreatment time of Trolox decreased the rate of cell death following UVB. In conclusion, UVB-induced signaling pathway activation is differentially modulated by Trolox. Further investigation into the time-dependent biologic activation of Trolox and its metabolic products, and modulation of signal transduction with cell outcome should facilitate development of rational strategies for pharmacologic applications.
Experimental Dermatology | 2004
Dominik Peus; Astrid Beyerle; Mariuca Vasa; Markus Pott; Alexander Meves; Mark R. Pittelkow
Abstract: Even though anthralin is a well‐established topical therapeutic agent for psoriasis, little is known about its effects and biochemical mechanisms of signal transduction. In contrast to a previous report, we found that anthralin induced time‐ and concentration‐dependent phosphorylation of epidermal growth factor receptor in primary human keratinocytes. Four lines of evidence show that this process is mediated by reactive oxygen species. First, we found that anthralin induces time‐dependent generation of H2O2. Second, there is a correlation between a time‐dependent increase in anthralin‐induced epidermal growth factor receptor phosphorylation and H2O2 generation. Third, the structurally different antioxidants n‐propyl gallate and N‐acetylcysteine inhibited epidermal growth factor receptor phosphorylation induced by anthralin. Fourth, overexpression of catalase inhibited this process. The epidermal growth factor receptor‐specific tyrosine kinase inhibitor PD153035 abrogated anthralin‐induced epidermal growth factor receptor phosphorylation and activation of extracellular‐regulated kinase 1/2. These findings establish the following sequence of events: (1) H2O2 generation, (2) epidermal growth factor receptor phosphorylation, and (3) extracellular‐regulated kinase activation. Our data identify anthralin‐induced reactive oxygen species and, more specifically, H2O2 as an important upstream mediator required for ligand‐independent epidermal growth factor receptor phosphorylation and downstream signaling.
Journal of Investigative Dermatology | 1999
Dominik Peus; R Vasa; Astrid Beyerle; Alexander Meves; Carsten Krautmacher; Mark R. Pittelkow
Journal of Investigative Dermatology | 1998
Dominik Peus; R Vasa; Alexander Meves; Markus Pott; Astrid Beyerle; Karen A. Squillace; Mark R. Pittelkow
Journal of Investigative Dermatology | 2002
Alexander Meves; Sibylle N. Stock; Astrid Beyerle; Mark R. Pittelkow; Dominik Peus
Journal of Dermatological Science | 1998
R Vasa; Dominik Peus; Astrid Beyerle; Pittelkow
Journal of Dermatological Science | 1998
Dominik Peus; R Vasa; Astrid Beyerle; Alexander Meves; Pittelkow